Insider trade

Charles River Laboratories (CRL): Officer received 5,456 shares

Joseph W Laplume, Officer at Charles River Laboratories, reported a grant / award of 5,456 shares.

5,456
Shares
Traded
Jan 30, 2026
Filed
Feb 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 22, 2025InsiderOfficer sold ~$65K of CRL shares in the open market
  2. Jan 8, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 8, 2026, the Board of Directors (the “Board”) of Charles River Laboratories International, Inc. (the “Company”) announced a leadership transition plan.”
  3. Jan 13, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  4. Jan 20, 2026Federal contract · $1.9M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $1.92M obligated to date

What came next

  1. Feb 10, 20265% stakeWellington Management Group LLP reported a passive stake (13G) of 3.6%
  2. Feb 12, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 5.5%
  3. Feb 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 18, 2026, the Company announced the appointment of Glenn Coleman as its Corporate Executive Vice President and Chief Financial Officer. Mr. Coleman will join the company with a tentative start date of April 6, 2026.”
  4. Feb 18, 2026Company filing · Form 8-K · ResultsReported its results
  5. Mar 3, 2026Insider · First insider buy since Feb 2025Officer purchased ~$4.4K of CRL shares in the open market
  6. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  7. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.4%
  8. May 5, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 5, 2026, Charles River Laboratories International, Inc. (the “Company”) held its 2026 annual meeting of shareholders (the “Annual Meeting”). As further discussed below, at the Annual Meeting, the shareholders of the Company approved the Company’s 2026 Long-Term Incentive Plan (the “2026 Incentive Plan”).”
  9. May 6, 20265% stakeFMR LLC reported a passive stake (13G) of 7.0%
  10. May 6, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 4.9%
  11. May 7, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Charles River Laboratories

For Charles River Laboratories, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRL page.

Other recent filings by Joseph W Laplume, EVP, Corp Strategy & Develop

The full history of Joseph W Laplume, EVP, Corp Strategy & Develop is on the profile page.

How this filing works

Explore the data

Common questions

Which Charles River Laboratories (CRL) insider traded, and how much?

Joseph W Laplume, Officer at Charles River Laboratories, reported a grant / award of 5,456 shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Jan 30, 2026. Filed: Feb 3, 2026. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Charles River Laboratories recently?

For Charles River Laboratories, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days. They are listed on the CRL page.

Does this mean CRL stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Charles River Laboratories

Everything OQRO holds on this company is on its CRL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data